Holen Sie sich die Stockscreener-App
4.195
1.08%
0.045
Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2,078%
3.5643
|
0.1636 | 0.2579 | 0.00195 | - |
| Operating Expenses |
8.83%
5.9972
|
6.5781 | 7.9348 | 4.0822 | 4.4503 |
| Benefits Costs and Expenses |
100.00%
-
|
6.2586 | 7.5646 | 3.638 | 4.0214 |
| Costs And Expenses |
4.18%
5.9972
|
6.2586 | 7.5646 | 3.638 | 4.0214 |
| Operating Income/Loss |
62.07%
-2.4329
|
-6.4145 | -7.6769 | -4.0803 | -4.4503 |
| Income/Loss From Continuing Operations Before Tax |
158.48%
3.5643
|
-6.095 | -7.3068 | -3.6361 | -4.0214 |
| Income/Loss From Continuing Operations After Tax |
65.29%
-2.1158
|
-6.095 | -7.3068 | -2.9158 | -4.0214 |
Net Income/Loss
|
65.29%
-2.1158
|
-6.095 | -7.3068 | -2.9158 | -4.0214 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.05%
16.73
|
16.72 | 16.72 | 0.3728 | 15.22 |
| Diluted Average Shares |
0.05%
16.73
|
16.72 | 16.72 | 0.3728 | 15.22 |
| Basic Earnings Per Share |
63.89%
-0.13
|
-0.36 | -0.44 | -0.18 | -0.26 |
| Diluted Earnings Per Share |
63.89%
-0.13
|
-0.36 | -0.44 | -0.18 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):